Jeevan Scientific Technology Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 300069,
    "name": "Jeevan Scienti.",
    "stock_name": "Jeevan Scienti.",
    "full_name": "Jeevan Scientific Technology Ltd",
    "name_url": "stocks-analysis/jeevan-scienti",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "64.08",
    "chg": 0.94,
    "chgp": "1.49%",
    "dir": 1,
    "prev_price": "63.14",
    "mcapval": "101.46 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538837,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE237B01018",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.96 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/jeevan-scienti-300069-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Jeevan Scienti. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jeevan-scienti-latest-results-good-or-bad-3698342",
        "imagepath": "",
        "date": "2025-11-13 19:33:26",
        "description": "Jeevan Scientific's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported net sales of ₹12.38 crores, reflecting an 8.60% year-on-year growth, which indicates some level of stabilization after a challenging previous quarter. However, this revenue growth is overshadowed by a significant decline in profitability, with a consolidated net loss of ₹0.09 crores, marking a stark contrast to the profit levels seen in the same quarter last year.\n\nThe operating margin stood at 16.72%, which, while showing a sequential recovery from a negative margin in the prior quarter, represents a notable contraction from the 21.93% achieved in Q2 FY24. This decline in margins is indicative of rising operational costs, particularly in employee expenses, which have outpaced revenue growth. The profit after tax margin has also diminished sharply to just 0.08%, down from 2.19%..."
      },
      {
        "title": "Jeevan Scientific Technology Shows Improved Financial Stability Amid Operational Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jeevan-scientific-technologys-financial-trend-improves-from-very-negative-to-flat-amid-stabilization-efforts-3697335",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JeevanScientifi_fintrenddot_3697335.png",
        "date": "2025-11-13 11:01:09",
        "description": "Jeevan Scientific Technology has shown improved financial stability in its latest quarter, with operating cash flow reaching Rs 10.07 crore. However, challenges persist, including a decline in profit after tax and low inventory and debtors turnover ratios. The company has outperformed the Sensex in recent market performance."
      },
      {
        "title": "Jeevan Scientific Q2 FY26: Marginal Recovery Masks Deeper Profitability Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/jeevan-scientific-q2-fy26-marginal-recovery-masks-deeper-profitability-crisis-3697661",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JeevanScientifi_quaterlyResult_3697661.png",
        "date": "2025-11-13 09:21:54",
        "description": "Jeevan Scientific Technology Ltd., a clinical contract research organisation, reported a consolidated net loss of ₹0.09 crores in Q2 FY26, marking a dramatic reversal from the ₹0.24 crores profit recorded in the same quarter last year. The micro-cap healthcare services company, with a market capitalisation of ₹98.17 crores, saw its stock trade at ₹62.00 following the results, reflecting a modest 0.26% gain as investors grappled with the company's persistent profitability challenges despite a sequential improvement in revenue."
      },
      {
        "title": "How has been the historical performance of Jeevan Scienti.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-jeevan-scienti-3695300",
        "imagepath": "",
        "date": "2025-11-13 00:15:24",
        "description": "Answer:\nThe historical performance of Jeevan Scienti shows a fluctuating trend in key financial metrics over the years.\n\nBreakdown:\nJeevan Scienti's net sales have seen a rise from 36.18 Cr in Mar'23 to 46.84 Cr in Mar'25, although they peaked at 67.79 Cr in Mar'22. The total operating income followed a similar pattern, increasing to 46.84 Cr in Mar'25 from 39.65 Cr in Mar'24, yet it remains below the 67.79 Cr recorded in Mar'22. The company's operating profit (PBDIT) has improved significantly, reaching 8.06 Cr in Mar'25 from 5.29 Cr in Mar'24, but it is still a decline from the 22.67 Cr in Mar'22. Profit before tax has shown a recovery to 0.05 Cr in Mar'25 from a loss of 1.60 Cr in Mar'24, while profit after tax also returned to a positive figure of 0.06 Cr in Mar'25, compared to a loss of 1.33 Cr in the previous year. The total assets of the company increased to 77.37 Cr in Mar'25 from 66.95 Cr in Mar'24..."
      },
      {
        "title": "When is the next results date for Jeevan Scienti.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-jeevan-scienti-3687232",
        "imagepath": "",
        "date": "2025-11-10 23:16:25",
        "description": "Jeevan Scienti. will declare its results on 12 November 2025...."
      },
      {
        "title": "Why is Jeevan Scienti. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jeevan-scienti-fallingrising-3680875",
        "imagepath": "",
        "date": "2025-11-07 22:43:55",
        "description": "As of 07-Nov, Jeevan Scientific Technology Ltd's stock price is currently at Rs 60.00, reflecting a decline of Rs 2.83, or 4.5%. The stock has underperformed its sector by 4.16% today and opened with a loss of 3.39%. It reached an intraday low of Rs 60, indicating significant selling pressure. Additionally, the stock's delivery volume has decreased by 9.68% compared to the 5-day average, suggesting a drop in investor participation. Over the past week, the stock has seen a decline of 7.64%, contrasting with a positive return of 49.93% over the past month, indicating recent volatility. Unfortunately, there is no information available regarding positive or negative factors that could provide further insight into the stock's recent movement.\n\nBroader market context shows that while Jeevan Scientific Technology Ltd has experienced a strong return of 21.09% year-to-date and 12.99% over the past year, its recent p..."
      }
    ],
    "total": 104,
    "sid": "300069",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/jeevan-scientific-technology-300069"
  },
  "announcements": [
    {
      "caption": "Closure Of The United States Food And Drug Administration (US FDA) Remote Regulatory Assessment Of JSTL And Issuance Of The Remote Regulatory Assessment Report - Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "22-Jan-2026",
      "details": "Disclosure under Regulation 30 of (LODR) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jan-2026",
      "details": "Compliances as per Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "07-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vanaja Kuchipudi Jeevan Kuchipudi and Krishna Kuchipudi",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jeevan Scientific Technology Ltd has declared <strong>12%</strong> dividend, ex-date: 21 Sep 22",
          "dt": "2022-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Jeevan Scienti. latest results good or bad?

2025-11-13 19:33:26

Jeevan Scientific's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported net sales of ₹12.38 crores, reflecting an 8.60% year-on-year growth, which indicates some level of stabilization after a challenging previous quarter. However, this revenue growth is overshadowed by a significant decline in profitability, with a consolidated net loss of ₹0.09 crores, marking a stark contrast to the profit levels seen in the same quarter last year. The operating margin stood at 16.72%, which, while showing a sequential recovery from a negative margin in the prior quarter, represents a notable contraction from the 21.93% achieved in Q2 FY24. This decline in margins is indicative of rising operational costs, particularly in employee expenses, which have outpaced revenue growth. The profit after tax margin has also diminished sharply to just 0.08%, down from 2.19%...

Jeevan Scientific Technology Shows Improved Financial Stability Amid Operational Challenges

2025-11-13 11:01:09

Jeevan Scientific Technology has shown improved financial stability in its latest quarter, with operating cash flow reaching Rs 10.07 crore. However, challenges persist, including a decline in profit after tax and low inventory and debtors turnover ratios. The company has outperformed the Sensex in recent market performance.

Jeevan Scientific Q2 FY26: Marginal Recovery Masks Deeper Profitability Crisis

2025-11-13 09:21:54

Jeevan Scientific Technology Ltd., a clinical contract research organisation, reported a consolidated net loss of ₹0.09 crores in Q2 FY26, marking a dramatic reversal from the ₹0.24 crores profit recorded in the same quarter last year. The micro-cap healthcare services company, with a market capitalisation of ₹98.17 crores, saw its stock trade at ₹62.00 following the results, reflecting a modest 0.26% gain as investors grappled with the company's persistent profitability challenges despite a sequential improvement in revenue.

How has been the historical performance of Jeevan Scienti.?

2025-11-13 00:15:24

Answer: The historical performance of Jeevan Scienti shows a fluctuating trend in key financial metrics over the years. Breakdown: Jeevan Scienti's net sales have seen a rise from 36.18 Cr in Mar'23 to 46.84 Cr in Mar'25, although they peaked at 67.79 Cr in Mar'22. The total operating income followed a similar pattern, increasing to 46.84 Cr in Mar'25 from 39.65 Cr in Mar'24, yet it remains below the 67.79 Cr recorded in Mar'22. The company's operating profit (PBDIT) has improved significantly, reaching 8.06 Cr in Mar'25 from 5.29 Cr in Mar'24, but it is still a decline from the 22.67 Cr in Mar'22. Profit before tax has shown a recovery to 0.05 Cr in Mar'25 from a loss of 1.60 Cr in Mar'24, while profit after tax also returned to a positive figure of 0.06 Cr in Mar'25, compared to a loss of 1.33 Cr in the previous year. The total assets of the company increased to 77.37 Cr in Mar'25 from 66.95 Cr in Mar'24...

When is the next results date for Jeevan Scienti.?

2025-11-10 23:16:25

Jeevan Scienti. will declare its results on 12 November 2025....

Why is Jeevan Scienti. falling/rising?

2025-11-07 22:43:55

As of 07-Nov, Jeevan Scientific Technology Ltd's stock price is currently at Rs 60.00, reflecting a decline of Rs 2.83, or 4.5%. The stock has underperformed its sector by 4.16% today and opened with a loss of 3.39%. It reached an intraday low of Rs 60, indicating significant selling pressure. Additionally, the stock's delivery volume has decreased by 9.68% compared to the 5-day average, suggesting a drop in investor participation. Over the past week, the stock has seen a decline of 7.64%, contrasting with a positive return of 49.93% over the past month, indicating recent volatility. Unfortunately, there is no information available regarding positive or negative factors that could provide further insight into the stock's recent movement. Broader market context shows that while Jeevan Scientific Technology Ltd has experienced a strong return of 21.09% year-to-date and 12.99% over the past year, its recent p...

View All News